Tenax Therapeutics TENX
NASDAQ TENX
$1.69 +0.00 (+0.00%)
At close: Nov 11, 2026 · 4:00 PM EST

Tenax Therapeutics (TENX) Dividends payables (2012)

Updated

Analysis

Tenax Therapeutics (TENX) Dividends payables (2012) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dividends payables (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 2.13 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Tenax Therapeutics 76.96 Mn -371.07 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Oct 31, 2012 14,863.00
Jul 31, 2012 14,384.00
Apr 30, 2012 21,479.00
API Access

Tenax Therapeutics Dividends payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=dividends-payables&ticker=TENX&period=max&api_key=YOUR_API_KEY